Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 29, 2023

SELL
$42.2 - $66.37 $51,315 - $80,705
-1,216 Reduced 18.11%
5,500 $347,000
Q1 2023

May 04, 2023

BUY
$37.97 - $50.0 $29,958 - $39,450
789 Added 13.31%
6,716 $302,000
Q4 2022

Feb 09, 2023

SELL
$41.06 - $66.48 $14,658 - $23,733
-357 Reduced 5.68%
5,927 $259,000
Q3 2022

Nov 07, 2022

SELL
$49.93 - $77.7 $20,121 - $31,313
-403 Reduced 6.03%
6,284 $414,000
Q2 2022

Jul 13, 2022

SELL
$45.23 - $70.15 $53,280 - $82,636
-1,178 Reduced 14.98%
6,687 $338,000
Q1 2022

May 05, 2022

BUY
$54.1 - $110.08 $94,945 - $193,190
1,755 Added 28.72%
7,865 $502,000
Q4 2021

Jan 24, 2022

BUY
$94.25 - $115.99 $11,404 - $14,034
121 Added 2.02%
6,110 $654,000
Q3 2021

Oct 22, 2021

BUY
$80.98 - $109.47 $82,113 - $111,002
1,014 Added 20.38%
5,989 $616,000
Q2 2021

Jul 23, 2021

BUY
$82.78 - $101.0 $105,213 - $128,371
1,271 Added 34.31%
4,975 $438,000
Q1 2021

Apr 09, 2021

BUY
$90.71 - $108.28 $124,363 - $148,451
1,371 Added 58.77%
3,704 $360,000
Q4 2020

Feb 05, 2021

SELL
$92.08 - $124.48 $10,128 - $13,692
-110 Reduced 4.5%
2,333 $262,000
Q3 2020

Nov 06, 2020

BUY
$66.45 - $92.7 $162,337 - $226,466
2,443 New
2,443 $226,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Efg Asset Management (Americas) Corp. Portfolio

Follow Efg Asset Management (Americas) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.